Key clinical point: Treatment costs are a significant influence on decision making on breast cancer treatment.
Major finding: Nearly half of women undergoing breast cancer treatment say cost is a factor when making decisions about treatment.
Study details: A survey of 607 women with a history of breast cancer.
Disclosures: The study was supported by the National Institutes of Health and the Duke Cancer Institute. Six authors reported honoraria, research funding, prior employment and other support from the pharmaceutical sector.
Greenup RA et al. J Oncol Pract. 2019 Jul 29. doi: 10.1200/JOP.18.00796.